The objective of this study is to investigate the significance of CK-18 M30 and MMP-2 levels in clinical use in patients with chronic hepatitis B (CHB), as well as their sensitivity in determining cirrhotic patients. This evidence concerns the gene KRT18 and chronic hepatitis B virus infection.